Abstract
The pharmacokinetics and gastric antisecretory effects of a new histamine H2-receptor antagonist, ranitidine hydrochloride, have been investigated in healthy subjects. In the pharmacokinetic study six subjects received 20 mg, 40 mg, and 80 mg ranitidine, both orally and intravenously. Plasma levels of ranitidine were dose-related and in most subjects after oral drug the concentration time curve was bimodal. The estimated elimination half-life was 140 minutes and the bioavailability of the oral drug was about 50%. Five subjects received bolus intravenous injections of ranitidine 20 mg, 40 mg, and 80 mg during continuous gastric stimulation with pentagastrin. There was a dose-related reduction in acid output (P less than 0.05).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bodemar G., Norlander B., Fransson L., Walan A. The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease. Br J Clin Pharmacol. 1979 Jan;7(1):23–31. doi: 10.1111/j.1365-2125.1979.tb00892.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bradshaw J., Brittain R. T., Clitherow J. W., Daly M. J., Jack D., Price B. J., Stables R. Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings]. Br J Pharmacol. 1979 Jul;66(3):464P–464P. [PMC free article] [PubMed] [Google Scholar]
- Burland W. L., Duncan W. A., Hesselbo T., Mills J. G., Sharpe P. C., Haggie S. J., Wyllie J. H. Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man. Br J Clin Pharmacol. 1975 Dec;2(6):481–486. doi: 10.1111/j.1365-2125.1975.tb00564.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Domschke W., Lux G., Domschke S. Gastric inhibitory action of H2-antagonists ranitidine and cimetidine. Lancet. 1979 Feb 10;1(8111):320–320. doi: 10.1016/s0140-6736(79)90728-1. [DOI] [PubMed] [Google Scholar]
- Hassan M. A., Hobsley M. Positioning of subject and of nasogastric tube during a gastric secretion study. Br Med J. 1970 Feb 21;1(5694):458–460. doi: 10.1136/bmj.1.5694.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peden N. R., Saunders J. H., Wormsley K. G. Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist. Lancet. 1979 Mar 31;1(8118):690–692. doi: 10.1016/s0140-6736(79)91146-2. [DOI] [PubMed] [Google Scholar]
- Thjodleifsson B., Wormsley K. G. Response to pentagastrin in Man. IV. Dose-response characteristics. Acta Hepatogastroenterol (Stuttg) 1976 Apr;23(2):124–130. [PubMed] [Google Scholar]